138 related articles for article (PubMed ID: 38704941)
1. Research progress of prodrugs for the treatment of cerebral ischemia.
Zheng H; Wu H; Wang D; Wang S; Ji D; Liu X; Gao G; Su X; Zhang Y; Ling Y
Eur J Med Chem; 2024 Jun; 272():116457. PubMed ID: 38704941
[TBL] [Abstract][Full Text] [Related]
2. Metabolic investigation on ZL006 for the discovery of a potent prodrug for the treatment of cerebral ischemia.
Chen D; Zhao T; Ni K; Dai P; Yang L; Xu Y; Li F
Bioorg Med Chem Lett; 2016 May; 26(9):2152-5. PubMed ID: 27025341
[TBL] [Abstract][Full Text] [Related]
3. Designing prodrugs for the treatment of Parkinson's disease.
Sozio P; Cerasa LS; Abbadessa A; Di Stefano A
Expert Opin Drug Discov; 2012 May; 7(5):385-406. PubMed ID: 22494466
[TBL] [Abstract][Full Text] [Related]
4. Sobetirome prodrug esters with enhanced blood-brain barrier permeability.
Placzek AT; Ferrara SJ; Hartley MD; Sanford-Crane HS; Meinig JM; Scanlan TS
Bioorg Med Chem; 2016 Nov; 24(22):5842-5854. PubMed ID: 27707627
[TBL] [Abstract][Full Text] [Related]
5. Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment.
Xiang H; Zhang Q; Han Y; Yang L; Zhang Y; Liu Q; Zhang Z; Zhang L
J Control Release; 2021 Jul; 335():498-514. PubMed ID: 34087248
[TBL] [Abstract][Full Text] [Related]
6. Green tea polyphenols alleviate early BBB damage during experimental focal cerebral ischemia through regulating tight junctions and PKCalpha signaling.
Liu X; Wang Z; Wang P; Yu B; Liu Y; Xue Y
BMC Complement Altern Med; 2013 Jul; 13():187. PubMed ID: 23870286
[TBL] [Abstract][Full Text] [Related]
7. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
[TBL] [Abstract][Full Text] [Related]
8. Design strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties.
Subbaiah MAM; Meanwell NA; Kadow JF
Eur J Med Chem; 2017 Oct; 139():865-883. PubMed ID: 28865281
[TBL] [Abstract][Full Text] [Related]
9. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
[TBL] [Abstract][Full Text] [Related]
10. A facile approach for synthesis of nano-CeO
Gao Y; Chen X; Liu H
J Photochem Photobiol B; 2018 Oct; 187():184-189. PubMed ID: 30173122
[TBL] [Abstract][Full Text] [Related]
11. Dl-3-N-Butylphthalide Alleviates the Blood-Brain Barrier Permeability of Focal Cerebral Ischemia Reperfusion in Mice.
Li J; Liu Y; Zhang X; Chen R; Zhang L; Xue J; Gao X
Neuroscience; 2019 Aug; 413():99-107. PubMed ID: 31247236
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier permeability of Gualou Guizhi granules and neuroprotective effects in ischemia/reperfusion injury.
Li H; Ye M; Zhang Y; Huang M; Xu W; Chu K; Chen L; Que J
Mol Med Rep; 2015 Jul; 12(1):1272-8. PubMed ID: 25815607
[TBL] [Abstract][Full Text] [Related]
13. Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges.
Ni G; Hu Z; Wang Z; Zhang M; Liu X; Yang G; Yan Z; Zhang Y
Oxid Med Cell Longev; 2022; 2022():4834117. PubMed ID: 35251474
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives.
Liu A; Hu J; Yeh TS; Wang C; Tang J; Huang X; Chen B; Huangfu L; Yu W; Zhang L
Curr Neuropharmacol; 2023; 21(11):2283-2309. PubMed ID: 37458258
[TBL] [Abstract][Full Text] [Related]
15. The neuroprotective effect of MicroRNA-149-5p and coenzymeQ10 by reducing levels of inflammatory cytokines and metalloproteinases following focal brain ischemia in rats.
Ghasemloo E; Oryan S; Bigdeli MR; Mostafavi H; Eskandari M
Brain Res Bull; 2021 Apr; 169():205-213. PubMed ID: 33508402
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical, preclinical pharmacokinetic and pharmaco-dynamic investigations of an orally administered novel 3-nbutylphthalide prodrug for ischemic stroke treatment.
Zhang Q; Han Y; Xiang H; Li M; Yang L; Liu Q; Zhang Y; Zhang Z; Lin Q; Zhang L
Eur J Pharm Sci; 2023 Jan; 180():106308. PubMed ID: 36272688
[TBL] [Abstract][Full Text] [Related]
17. XingNaoJing injections protect against cerebral ischemia/reperfusion injury and alleviate blood-brain barrier disruption in rats, through an underlying mechanism of NLRP3 inflammasomes suppression.
Qu XY; Zhang YM; Tao LN; Gao H; Zhai JH; Sun JM; Song YQ; Zhang SX
Chin J Nat Med; 2019 Jul; 17(7):498-505. PubMed ID: 31514981
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of HET0016 on brain edema and blood-brain barrier dysfunction after cerebral ischemia/reperfusion.
Liu Y; Wang D; Wang H; Qu Y; Xiao X; Zhu Y
Brain Res; 2014 Jan; 1544():45-53. PubMed ID: 24316243
[TBL] [Abstract][Full Text] [Related]
19. Pigment Epithelium-Derived Factor Improves Paracellular Blood-Brain Barrier Integrity in the Normal and Ischemic Mouse Brain.
Riabinska A; Zille M; Terzi MY; Cordell R; Nieminen-Kelhä M; Klohs J; Piña AL
Cell Mol Neurobiol; 2020 Jul; 40(5):751-764. PubMed ID: 31858356
[TBL] [Abstract][Full Text] [Related]
20. IMM-H004, A New Coumarin Derivative, Improved Focal Cerebral Ischemia via Blood-Brain Barrier Protection in Rats.
Niu F; Song XY; Hu JF; Zuo W; Kong LL; Wang XF; Han N; Chen NH
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2065-2073. PubMed ID: 28669655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
